Catalyst Wire Dossier Catalyst Wire Dossier

Svariya

rivaroxaban · Koanaa Healthcare GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Svariya, covering 2026-08-25 to 2026-08-25. Get the full timeline:

Most recent: EMA Authorised: Svariya (previously Rivaroxaban Koanaa) (rivaroxaban) — Koanaa Healthcare GmbH

See pricing